Sign in

CIK 0001124105

  • Accelerated filer
  • Smaller reporting company

GYRE THERAPEUTICS, INC.

Sign in to watch
Ticker
GYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
562020050
Phone
+1 858-284-0115
Business address
12730 HIGH BLUFF DRIVE, SUITE 250, SAN DIEGO, CA, 92130
Former names
CATALYST BIOSCIENCES, INC., TARGACEPT INC
  1. 4 Option exercise 10% owner acquired 3,333 shares (option exercise)
  2. 4 Open-market buy 10% owner bought 1,290,212 shares at an average $4.06 ($5,242,308)
  3. 4 Open-market buy 10% owner bought 72,429 shares at an average $4.03 ($291,927)
  4. 4 Open-market buy 10% owner bought 139,700 shares at an average $4.05 ($566,178)
  5. 3 Insider Initial Statement of Ownership
  6. 4 Exercise or conversion Director acquired 4,333 shares (option exercise)
  7. 3 Insider Initial Statement of Ownership
  8. 4 Derivatives Options or other derivatives
  9. 4 Open-market buy Director bought 7,500 shares at $4.16 ($31,193)
  10. 3 Insider Initial Statement of Ownership
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Exercise or conversion SVP, Preclinical Research acquired 15,938 shares (option exercise)
  20. 4 Derivatives Options or other derivatives

Page 22 of 37 · 739 filings